Net loss per share (Details) - Schedule of antidilutive securities excluded from computation of earnings per share - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
|
| Schedule of antidilutive securities excluded from computation of earnings per share [Abstract] | ||||
| Options to purchase common stock | 822,457 | 786,047 | 822,457 | 786,047 |
| Warrants to purchase common stock (in Dollars) | $ 4,784,193 | $ 4,784,193 | ||
| Total | 5,606,650 | 786,047 | 5,606,650 | 786,047 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|